BFC Planning’s Azora Therapeutics AZR Stock Holding History
Bought
Maintained
Sold
Other funds holding AZR
BFC Planning's AZR Position: Q1 2026 in Review
BFC Planning sold out of Azora Therapeutics (AZR) in Q1 2026, closing a stake of 1 share — an estimated $6 sold.
BFC Planning first reported a position in AZR in Q3 2024 and held it in 5 quarters. The position peaked at $28 in Q4 2024. 15 funds tracked by Wall St. Rank hold AZR as of Q1 2026.
- BFC Planning reported no remaining Azora Therapeutics position as of Q1 2026 after selling out during the quarter.
- BFC Planning sold 1 Azora Therapeutics share in Q1 2026, an estimated $6.
- BFC Planning first reported a position in Azora Therapeutics in Q3 2024 and held it in 5 quarters.
- BFC Planning's Azora Therapeutics position peaked at $28 in Q4 2024.
- 15 funds tracked by Wall St. Rank held Azora Therapeutics as of Q1 2026.
Based on BFC Planning's 13F filing for Q1 2026, filed 29 Oct 2026.